UNSPSC 51392605: Metaraminol bitartrate

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H13NO2.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZC4202M9P3, chemically known as (-)-.alpha.-(1-aminoethyl)-m-hydroxybenzyl alcohol tartrate (1:1) (salt), but more generally known as metaraminol bitartrate, which bears US NIH Compound Identifier 5906. European Medicines Agency schedules metaraminol bitartrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08815MIG.

UNSPSC 51392605 Metaraminol bitartrate is a Commodity code that nominally describes a specific pharmaceutical ingredient, but recent state and local procurement activity under this code shows minimal alignment with that narrow scope. The single recent opportunity on file is Seminole County, Florida's IFB60459723LAS, posted June 30, 2026 with response due July 26, 2023, which solicits naloxone and safe drug deactivation systems—products substantially different from the code's stated commodity. The mismatch suggests either a classification error in the county's tagging or a broader interpretation of the code that state and local procurement systems have not consistently applied. State and local governments tagging under this code appear to include county health and safety departments pursuing community health initiatives, though the single recent record limits visibility into the broader issuing-body pattern.

Geographic activity is concentrated in Florida based on the available record. Seminole County's procurement calls for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option, requires vendors to include all shipping and delivery costs in their bid, and imposes standard compliance obligations including drug-free workplace certification, E-Verify confirmation, and insurance coverage minimums. The procurement does not designate set-asides for disadvantaged enterprises. The source provides no other recent opportunities under this code, limiting ability to characterize geographic spread or issuing-body concentration beyond this single Florida county procurement.